XML 178 R152.htm IDEA: XBRL DOCUMENT v3.23.4
STOCK-BASED COMPENSATION - Vallon - 10-K - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Unrecognized compensation cost, options $ 424   $ 424      
Stock-based compensation $ 326 $ 0 $ 351 $ 0    
Vallon Pharmaceuticals, Inc.            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Outstanding, intrinsic value         $ 0  
Unrecognized compensation cost, options         $ 753  
Unrecognized compensation, weighted average amortization period (in years)         2 years 7 months 20 days  
Stock-based compensation         $ 99 $ 626
Stock options            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Unrecognized compensation, weighted average amortization period (in years)     3 years 1 month 28 days      
Stock options | Vallon Pharmaceuticals, Inc.            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Stock awards, contractual life (in years)         10 years  
RSUs            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Awards unvested (in shares)         0  
RSUs | Vallon Pharmaceuticals, Inc.            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Awards granted (in shares)         188,023  
Grant date fair value (in usd per share)         $ 0.5683  
Awards unvested (in shares)         0 0
Performance-based RSUs | Vallon Pharmaceuticals, Inc.            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Awards granted (in shares)         150,000  
Percentage of milestone achieved         50.00%  
Stock-based compensation         $ 42  
Time-based RSUs | Vallon Pharmaceuticals, Inc.            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Awards granted (in shares)         38,023  
Stock-based compensation         $ 24